Anionic fullerenes, calixarenes, coronenes, and pyrenes as activators of oligo/polyarginines in model membranes and live cells

Journal of the American Chemical Society

Volumn 127, Issue 4, 2005, Pages 1114-1115

  Perret, Florent ^a   Nishihara, Masamichi ^a   Takeuchi, Toshihide ^b   Futaki, Shiroh ^b,c   Lazar, Adina N ^d   Coleman, Anthony W ^d   Sakai, Naomi ^a   Matile, Stefan ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b KYOTO UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOPHILE; ANION; ARGININE DERIVATIVE; BUTYRIC ACID DERIVATIVE; CALIXARENE; CELL PROTEIN; CORONENEBUTYRATE; FULLERENE DERIVATIVE; PHOSPHATIDYLGLYCEROL; POLYARGININE; PYRENE DERIVATIVE; PYRENEBUTYRATE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MEMBRANE; CATALYSIS; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIPID BILAYER; MEMBRANE VESICLE; PHASE TRANSITION;

ANIONS; CALIXARENES; CELL MEMBRANE; DRUG CARRIERS; FULLERENES; HELA CELLS; HUMANS; MEMBRANES, ARTIFICIAL; PEPTIDES; PHOSPHATIDYLGLYCEROLS; POLYCYCLIC COMPOUNDS; PYRENES;

EID: 13644271605     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja043633c     Document Type: Article

References (21)

1. Sakai, N.; Matile, S. J. Am. Chem. Soc. 2003, 125, 14348-14356.
2. Sakai, N.; Takeuchi, T.; Futaki, S.; Matile, S. ChemBioChem, in press, and references therein.
3. 8) into octanol using laurate as a counter-anion has recently been reported: (a) Rothbard, J. B.; Jessop, T. C.; Lewis, R. S.; Murray, B. A.; Wender, P. A. J. Am. Chem. Soc. 2004, 126, 9506-9507. Compare also: (b) Dom, G.; Shaw-Jackson, C.; Matis, C.; Bouffioux, O.; Picard, J. J.; Prochiantz, A.; Mingeot-Leclercq, M. P.; Brasseur, R.; Rezsohazy, R. Nucleic Acids Res. 2003, 31, 556-561.
4. 8) into octanol using laurate as a counter-anion has recently been reported: (a) Rothbard, J. B.; Jessop, T. C.; Lewis, R. S.; Murray, B. A.; Wender, P. A. J. Am. Chem. Soc. 2004, 126, 9506-9507. Compare also: (b) Dom, G.; Shaw-Jackson, C.; Matis, C.; Bouffioux, O.; Picard, J. J.; Prochiantz, A.; Mingeot-Leclercq, M. P.; Brasseur, R.; Rezsohazy, R. Nucleic Acids Res. 2003, 31, 556-561.
5. 1,2 cannot be excluded in vesicles either, although activity in DPPC vesicles below phase transition was poor and neither ion-channel formation nor membrane disruption could be observed in planar EYPC/EYPG-bilayer experiments.
6. (a) Jones, O. T.; Lee, A. G. Biochemistry 1985, 24, 2195-2202.
7. (b) Martins, J.; Melo, E. Biophys. J. 2001, 80, 832-840.
8. Please see the Supporting Information.
9. max depended on nature as well as concentration of oligo/polyarginine (not shown); the possibility of systematic batch-to-batch errors required attention to eventually necessary calibration.
10. 1
11. Inactivity of alcohols corresponding to all sulfates and some carboxylates listed in Figure 1 confirmed, however, that low-affinity ion pairing is essential.
12. (a) Schiffer, M.; Chang, C. H.; Stevens, F. J. Protein Eng. 1992, 5, 213-214.
13. (b) Yau, W. M.; Wimley, W. C.; Gawrisch, K.; White, S. H. Biochemistry 1998, 37, 14713-14718.
14. (a) Thompson, S. E.; Smithrud, D. B. J. Am. Chem. Soc. 2002, 124, 442-449.
15. (b) Orner, B. P.; Salvatella. X.; Sánchez-Quesada, J.; de Mendoza, J.; Giralt, E.; Hamilton, A. D. Angew. Chem., Int. Ed. 2002, 41, 117-119.
16. Davenport, L.; Shen, B.; Joseph, T. W.; Straher, M. P. Chem. Phys. Lipids 2001, 109, 145-156.
17. Da Silva, E.; Lazar, A. N.; Coleman, A. W. J. Drug Del. Sci. Technol. 2004, 14, 3-20.
18. Whereas ring expansion to calix[6]arenes reduced activator efficiency, additional carboxylates on one face and alkyls on the other face of calix-[4]arenes were tolerated. Several calix[4]arene carboxylates with sulfates at the upper rim were inactive, presumably because the resulting complexes were too hydrophilic.
19. (a) Bingel, C. Chem. Ber. 1993, 126, 1957-1959.
20. (b) Nakamura, E.; Isobe, H. Acc. Chem. Res. 2003, 36, 807-815.
21. (c) Foley, S.; Crowley, C.; Smaihi, M.; Bonfils, C.; Erlanger, B. F.; Seta, P.; Larroque, C. Biochem. Biophys. Res. Commun. 2002, 294, 116-119.